Andrew Robbins

Chief Executive Officer at COGENT BIOSCIENCES, INC.

Net worth: 23 M $ as of 31/05/2026

50 year

61 connections

Health Technology

Consumer Services

Finance

Profile

Andrew R.
Robbins is President, Chief Executive Officer & Director at Cogent Biosciences, Inc. since 2020.
Mr. Robbins is also an Independent Director at Turmeric Acquisition Corp.
since 2020.
Former roles include Independent Director at Harpoon Therapeutics, Inc. from 2020 to 2024; Chief Operating Officer at Array BioPharma, Inc. from 2015 to 2019; Senior Vice President-Commercial Operations at Pfizer Inc. from 2012 to 2015; General Manager & Vice President at Hospira, Inc. from 2007 to 2012; and Director positions at Cytograft Tissue Engineering, Inc., StemCor Systems, Inc., and Fate Therapeutics, Inc. Education includes undergraduate studies at Swarthmore College and an MBA from Kellogg School of Management.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
COGENT BIOSCIENCES, INC. 0.38%	19/05/2026	657,503 ( 0.38% )	23 M $	31/05/2026

Andrew Robbins active positions

Companies	Position	Start
TURMERIC ACQUISITION CORP.	Director/Board Member	01/10/2020
COGENT BIOSCIENCES, INC.	Chief Executive Officer	23/10/2020

All active positions of Andrew Robbins

Former positions of Andrew Robbins

Companies	Position	End
HARPOON THERAPEUTICS, INC.	Director/Board Member	11/03/2024
ARRAY TECHNOLOGIES, INC.	Chief Operating Officer	01/01/2019
PFIZER INC.	Chief Operating Officer	01/03/2015
HOSPIRA, INC.	Corporate Officer/Principal	01/07/2012
StemCor Systems, Inc. StemCor Systems, Inc. Medical SpecialtiesHealth Technology Develops proprietary and minimally-invasive bone marrow collection systems	Director/Board Member	-

See the detail of Andrew Robbins's experience

Training of Andrew Robbins

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Robbins's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Array BioPharma, Inc. Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs	Health Technology
Hospira, Inc. Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services	Health Technology
Cytograft Tissue Engineering, Inc. Cytograft Tissue Engineering, Inc. Pharmaceuticals: MajorHealth Technology Develops cardiovascular medicine	Health Technology
StemCor Systems, Inc. StemCor Systems, Inc. Medical SpecialtiesHealth Technology Develops proprietary and minimally-invasive bone marrow collection systems	Health Technology
Cogent Biosciences, Inc. Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer	Health Technology
Swarthmore College Swarthmore College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fate Therapeutics, Inc. Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company	Health Technology
Kellogg School of Management Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harpoon Therapeutics, Inc. Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases	Health Technology
Turmeric Acquisition Corp. Turmeric Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance